These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
2355 related items for PubMed ID: 11594942
1. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Age-Related Eye Disease Study Research Group. Arch Ophthalmol; 2001 Oct; 119(10):1417-36. PubMed ID: 11594942 [Abstract] [Full Text] [Related]
3. Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD, Age-Related Eye Disease Study Research Group. Ophthalmology; 2013 Aug; 120(8):1604-11.e4. PubMed ID: 23582353 [Abstract] [Full Text] [Related]
4. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Evans JR, Lawrenson JG. Cochrane Database Syst Rev; 2023 Sep 13; 9(9):CD000254. PubMed ID: 37702300 [Abstract] [Full Text] [Related]
7. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Davis MD, Ferris FL, Age-Related Eye Disease Study Research Group. JAMA Ophthalmol; 2014 Mar 13; 132(3):272-7. PubMed ID: 24385141 [Abstract] [Full Text] [Related]
8. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Evans JR, Lawrenson JG. Cochrane Database Syst Rev; 2017 Jul 31; 7(7):CD000254. PubMed ID: 28756618 [Abstract] [Full Text] [Related]
9. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Clemons TE, Kurinij N, Sperduto RD, AREDS Research Group. Arch Ophthalmol; 2004 May 31; 122(5):716-26. PubMed ID: 15136320 [Abstract] [Full Text] [Related]
10. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Awh CC, Lane AM, Hawken S, Zanke B, Kim IK. Ophthalmology; 2013 Nov 31; 120(11):2317-23. PubMed ID: 23972322 [Abstract] [Full Text] [Related]
11. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD. JAMA Ophthalmol; 2014 Feb 31; 132(2):142-9. PubMed ID: 24310343 [Abstract] [Full Text] [Related]
12. Current use of dietary supplementation in patients with age-related macular degeneration. Chang CW, Chu G, Hinz BJ, Greve MD. Can J Ophthalmol; 2003 Feb 31; 38(1):27-32. PubMed ID: 12608514 [Abstract] [Full Text] [Related]
13. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). AREDS2 Research GroupDivision of Epidemiology and Clinical Applications, National Eye Institute/National Institutes of Health, Bethesda, Maryland, USA. echew@nei.nih.gov, Chew EY, Clemons T, SanGiovanni JP, Danis R, Domalpally A, McBee W, Sperduto R, Ferris FL. Ophthalmology; 2012 Nov 31; 119(11):2282-9. PubMed ID: 22840421 [Abstract] [Full Text] [Related]